VenetoclaxClinical tumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35548-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：408 / 408

相关论文

共 50 条

[41] AlectinibElevated alkaline phosphatase and tumour lysis syndrome: case report
Reactions Weekly, 2022, 1891 (1) : 16 - 16
[42] Ibrutinib/venetoclaxFatal hyperkalaemia and tumour lysis syndrome: case report
Reactions Weekly, 2020, 1787 (1) : 273 - 273
[43] Furosemide\ifosfamide\rasburicaseFatal tumour lysis syndrome: case report
Reactions Weekly, 2022, 1920 (1) : 231 - 231
[44] AntineoplasticsBreast erythema secondary to tumour lysis syndrome: case report
Reactions Weekly, 2018, 1694 (1) : 36 - 36
[45] AntineoplasticsCalcinosis cutis secondary to tumour lysis syndrome: case report
Reactions Weekly, 2019, 1757 (1) : 35 - 35
[46] DexamethasoneFatal acute tumour lysis syndrome in a child: case report
Reactions Weekly, 2008, 1203 (1) : 17 - 17
[47] Cyclophosphamide/prednisolone/vincristineClinical tumour lysis syndrome: case report
Reactions Weekly, 2018, 1729 (1) : 88 - 88
[48] Blinatumomab/tisagenlecleucelCytokine release syndrome, pancytopenia and tumour lysis syndrome: case report
Reactions Weekly, 2022, 1919 (1) : 149 - 149
[49] RuxolitinibWithdrawal syndrome leading to tumour lysis syndrome in an elderly patient: case report
Reactions Weekly, 2014, 1496 (1) : 35 - 35
[50] AtezolizumabCytokine release syndrome, tumour lysis syndrome and autoimmune toxicity: case report
Reactions Weekly, 2020, 1805 (1) : 53 - 53

← 1 2 3 4 5 →